7Baggers

Vertex Pharmaceuticals Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Deferred Revenue  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 049.9799.93149.9199.86249.83299.79349.76Milllion

Vertex Pharmaceuticals Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 
                       
  ​                     
  assets                     
  current assets:                     
  cash and cash equivalents284,386,000 270,395,000 296,051,000 278,979,000 325,535,000 56,134,000 68,175,000 49,499,000 41,865,000 68,643,000 91,803,000 72,370,000 85,554,000 97,340,000 73,333,000 47,481,000 101,593,000 277,681,000 303,051,000 270,271,000 47,295,000 
  funds held for customers26,376,000 33,287,000 30,015,000 26,407,000 35,408,000 36,546,000 20,976,000 31,623,000 30,156,000 25,972,000 14,945,000 23,840,000 19,935,000 25,899,000 24,873,000 27,860,000 31,060,000 8,745,000 9,222,000 8,745,000 9,988,000 
  accounts receivable143,660,000 152,338,000 164,432,000 129,908,000 120,082,000 133,149,000 141,752,000 129,018,000 129,093,000 102,760,000 102,885,000 94,529,000 88,961,000 75,807,000 76,929,000 73,234,000 73,130,000 63,798,000 77,159,000 66,789,000 63,739,000 
  prepaid expenses and other current assets48,309,000 48,942,000 36,678,000 33,863,000 25,134,000 31,906,000 26,173,000 19,637,000 22,026,000 22,536,000 20,383,000 22,494,000 22,956,000 21,513,000 20,536,000 18,167,000 17,593,000 26,696,000 13,259,000 16,001,000 13,119,000 
  investment securities available-for-sale, at fair value  9,157,000 7,462,000 8,650,000 9,101,000 9,545,000 8,326,000 11,201,000             
  total current assets502,731,000 504,962,000 536,333,000 476,619,000 514,809,000 266,836,000 266,621,000 238,103,000 234,341,000 231,435,000 241,189,000 219,360,000 224,349,000 220,559,000 195,671,000 166,742,000 223,376,000 376,920,000 402,691,000 361,808,000 134,371,000 
  property and equipment, net of accumulated depreciation195,034,000 185,557,000 177,559,000 178,578,000 108,407,000 100,594,000 100,734,000 100,270,000 98,912,000 117,444,000 115,768,000 109,123,000 106,526,000 102,228,000 98,390,000 97,869,000 61,611,000 57,408,000 56,557,000 55,935,000 55,657,000 
  capitalized software, net of accumulated amortization35,659,000 36,219,000 36,350,000 36,864,000 37,840,000 38,532,000 38,771,000 39,356,000 39,461,000 38,790,000 39,012,000 38,561,000 38,362,000 33,053,000 33,442,000 34,018,000 34,364,000 34,642,000 31,989,000 32,619,000 33,761,000 
  goodwill and other intangible assets397,312,000 374,312,000 363,021,000 388,716,000 252,183,000 255,681,000 260,238,000 253,976,000 259,587,000 259,303,000 257,023,000 245,284,000 255,556,000 272,633,000 272,702,000 277,924,000 220,818,000 21,553,000 18,711,000   
  deferred commissions27,737,000 27,535,000 27,480,000 22,540,000 21,862,000 21,301,000 21,237,000 17,094,000 16,726,000 15,921,000 15,463,000 13,757,000 12,168,000 11,679,000 12,555,000 12,583,000 11,545,000 11,693,000 11,743,000 10,372,000 10,390,000 
  deferred income tax asset20,000 19,000 19,000 61,193,000 61,897,000 44,311,000 41,708,000 40,557,000 42,855,000 43,542,000 30,938,000 30,716,000 31,190,000 34,554,000 35,298,000 32,816,000 32,573,000 30,373,000 29,974,000 32,440,000  
  operating lease right-of-use assets11,344,000 11,189,000 11,956,000 12,567,000 13,060,000 13,773,000 14,605,000 15,333,000 16,564,000 16,462,000 17,187,000 18,089,000 19,007,000 19,644,000 20,249,000 21,137,000 22,156,000 22,981,000    
  long-term investment15,000,000                     
  other assets13,352,000 14,351,000 14,073,000 13,763,000 13,772,000 14,774,000 16,013,000 15,379,000 16,624,000 2,621,000 2,612,000 2,422,000 2,592,000 3,158,000 1,900,000 2,755,000 3,086,000 2,767,000 3,263,000   
  total assets1,198,189,000 1,154,144,000 1,166,791,000 1,190,840,000 1,023,830,000 755,802,000 759,927,000 720,068,000 725,070,000 725,518,000 719,192,000 677,312,000 689,750,000 697,508,000 670,207,000 645,844,000 609,529,000 558,337,000 554,928,000 514,934,000 258,490,000 
  liabilities and stockholders' equity                     
  current liabilities:                     
  accounts payable30,440,000 24,979,000 36,215,000 29,229,000 24,220,000 22,431,000 23,596,000 24,379,000 22,009,000 17,420,000 14,329,000 13,052,000 17,710,000 14,578,000 13,000,000 10,701,000 11,694,000 11,115,000 8,876,000 11,828,000 13,769,000 
  accrued expenses42,155,000 38,114,000 35,169,000 44,643,000 41,767,000 36,754,000 44,735,000 49,614,000 55,991,000 55,896,000 38,234,000 28,908,000 23,931,000 27,286,000 22,966,000 23,467,000 19,974,000 15,936,000 19,176,000 15,014,000 11,961,000 
  customer funds obligations23,913,000 30,632,000 27,406,000 23,762,000 32,710,000 33,670,000 17,731,000 29,117,000 26,594,000 23,110,000 12,121,000 20,858,000 18,890,000 24,507,000 23,461,000 27,979,000 31,462,000 8,798,000 9,235,000 8,711,000 10,175,000 
  accrued salaries and benefits14,873,000 21,768,000 14,581,000 20,025,000 13,251,000 18,659,000 12,277,000 17,355,000 12,332,000 15,142,000 10,790,000 14,937,000 16,223,000 13,992,000 16,671,000 26,472,000 22,994,000 18,065,000 17,326,000 20,276,000 19,825,000 
  accrued variable compensation19,000,000 14,144,000 45,507,000 35,391,000 25,727,000 14,562,000 34,105,000 23,232,000 15,027,000 8,045,000 23,729,000 19,585,000 13,480,000 9,917,000 26,462,000   5,854,000 22,372,000 16,154,000 11,025,000 
  deferred revenue, current341,754,000 349,757,000 339,326,000 300,620,000 297,305,000 296,845,000 290,143,000 264,785,000 274,094,000 276,004,000 268,847,000 242,637,000 243,815,000 235,236,000        
  current portion of operating lease liabilities4,228,000 4,043,000 3,995,000 3,863,000 3,799,000 3,633,000 3,717,000 4,198,000 4,454,000 3,141,000 4,086,000 4,278,000 4,306,000 4,145,000 3,933,000 2,480,000 3,641,000 4,665,000    
  current portion of finance lease liabilities61,000 77,000 77,000 88,000 90,000 60,000 74,000 84,000 59,000 75,000 103,000 967,000 2,368,000 286,000 284,000 276,000 271,000 267,000    
  purchase commitment and contingent consideration liabilities, current29,900,000 29,600,000 35,100,000 300,000 200,000 13,390,000 11,901,000 7,842,000 7,866,000 8,340,000 6,149,000 5,082,000 4,791,000 1,258,000 468,000 478,000 10,458,000 767,000    
  total current liabilities506,324,000 513,114,000 537,376,000 457,921,000 439,069,000 442,504,000 440,779,000 433,106,000 430,900,000 421,949,000 403,209,000 373,970,000 368,876,000 356,562,000 369,132,000 345,695,000 326,729,000 275,195,000 291,968,000 263,515,000 278,519,000 
  deferred revenue, net of current portion5,496,000 5,140,000 4,840,000 3,792,000 2,436,000 4,146,000 2,577,000 2,030,000 2,959,000 7,112,000 10,289,000 11,098,000 11,259,000 10,479,000 11,666,000 11,544,000 12,025,000 13,162,000 14,702,000 12,095,000 11,396,000 
  debt, net of current portion336,349,000 335,784,000 335,220,000 334,656,000 334,092,000 43,458,000 44,059,000 44,863,000 45,478,000 46,093,000 46,709,000 47,324,000 47,939,000 48,554,000        
  operating lease liabilities, net of current portion11,253,000 11,461,000 12,585,000 13,568,000 14,397,000 15,523,000 16,567,000 17,445,000 18,330,000 20,057,000 20,421,000 21,431,000 22,371,000 23,360,000 24,320,000 26,707,000 26,726,000 26,671,000    
  finance lease liabilities, net of current portion  10,000 20,000 36,000 41,000 51,000 65,000   10,000 24,000 39,000 68,000 68,000 334,000 334,000 334,000    
  purchase commitment and contingent consideration liabilities, net of current portion80,200,000 78,200,000 87,400,000 105,000,000   2,600,000 2,200,000 1,500,000 6,813,000 8,412,000 8,009,000 7,488,000 12,152,000 10,829,000 11,049,000 11,610,000 10,287,000    
  deferred income tax liabilities9,369,000 9,369,000 9,918,000 16,187,000                  
  deferred other liabilities1,156,000 586,000 90,000 670,000 670,000  313,000 187,000 188,000 19,000 417,000 1,416,000 1,428,000 1,927,000 2,726,000 4,199,000 17,000 64,000 8,632,000 8,793,000 8,865,000 
  total liabilities950,147,000 953,654,000 987,439,000 931,814,000 790,700,000 505,672,000 506,946,000 499,896,000 499,355,000 502,043,000 489,467,000 463,272,000 469,115,000 464,677,000 440,123,000 421,633,000 381,685,000 331,761,000 329,442,000 296,373,000 559,477,000 
  commitments and contingencies                     
  stockholders' equity:                     
  preferred shares, 0.001 par value, 30,000 shares authorized; no shares issued and outstanding                     
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 77,242 and 70,670 shares issued and outstanding, respectively77,000                     
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 82,156 and 86,481 shares issued and outstanding, respectively82,000                     
  additional paid in capital292,078,000 273,300,000 278,389,000 264,494,000 254,799,000 273,647,000 275,155,000 265,251,000 262,095,000 253,566,000 244,820,000 238,093,000 232,850,000 227,751,000 222,621,000 215,647,000 209,629,000 205,811,000 206,541,000 200,722,000  
  accumulated deficit-43,146,000 -42,185,000 -53,315,000                  -305,861,000 
  accumulated other comprehensive loss-1,049,000 -30,783,000 -45,879,000 -20,107,000 -29,086,000 -25,770,000 -21,742,000 -29,312,000 -24,011,000 -24,617,000 -27,752,000 -42,019,000 -31,321,000 -19,546,000 -17,497,000 -13,167,000 -7,463,000 -4,104,000 -3,127,000 -4,003,000 -3,765,000 
  total stockholders' equity248,042,000 200,490,000 179,352,000 259,026,000 233,130,000 250,130,000 252,981,000 220,172,000 225,715,000 223,475,000 229,725,000 214,040,000 220,635,000 232,831,000 230,084,000 224,211,000 227,844,000 226,576,000 225,486,000 218,561,000  
  total liabilities and stockholders' equity1,198,189,000 1,154,144,000 1,166,791,000 1,190,840,000 1,023,830,000 755,802,000 759,927,000 720,068,000 725,070,000 725,518,000 719,192,000 677,312,000 689,750,000 697,508,000 670,207,000 645,844,000 609,529,000     
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 71,907 and 70,670 shares issued and outstanding, respectively 72,000                    
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 86,481 and 86,481 shares issued and outstanding, respectively 86,000                    
  current portion of long-term debt     2,500,000 2,500,000 2,500,000 2,500,000 2,500,000 2,188,000 1,875,000 1,563,000 1,250,000     882,000 1,179,000 649,000 
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 70,670 and 60,989 shares issued and outstanding, respectively  71,000                   
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 86,481 and 92,661 shares issued and outstanding, respectively  86,000                   
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 65,722 and 60,989 shares issued and outstanding, respectively   66,000                  
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 90,161 and 92,661 shares issued and outstanding, respectively   90,000 90,000                 
  retained earnings   14,483,000 7,262,000 2,098,000     12,507,000 17,816,000 18,957,000 24,477,000 24,811,000 21,582,000 25,530,000 24,722,000 21,926,000 21,696,000  
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 65,165 and 60,989 shares issued and outstanding, respectively    65,000                 
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 62,316 and 60,989 shares issued and outstanding, respectively     62,000                
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 92,661 and 92,661 shares issued and outstanding, respectively     93,000                
  deferred compensation, current         2,352,000 2,809,000 2,067,000 1,844,000 4,202,000 4,202,000   2,057,000 2,057,000 3,220,000 22,349,000 
  deferred purchase consideration, current       10,000,000 9,974,000 9,924,000 19,824,000 19,724,000 19,955,000 19,905,000 19,805,000 19,705,000      
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 60,989 and 50,014 shares issued and outstanding, respectively      61,000               
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 92,661 and 100,307 shares issued and outstanding, respectively      93,000               
  (accumulated deficit) retained earnings      -586,000 -15,920,000 -12,521,000 -5,625,000            
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 55,825 and 50,014 shares issued and outstanding, respectively       56,000              
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 96,839 and 100,307 shares issued and outstanding, respectively       97,000              
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 54,054 and 50,014 shares issued and outstanding, respectively        54,000             
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 97,718 and 100,307 shares issued and outstanding, respectively        98,000 98,000            
  investment securities available-for-sale, current, at fair value         11,524,000 11,173,000           
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 53,586 and 50,014 shares issued and outstanding, respectively         53,000            
  tax sharing agreement distributions payable              536,000       
  deferred compensation, net of current portion            129,000 2,056,000 1,963,000 2,786,000 4,244,000 6,048,000 5,010,000 2,156,000 77,505,000 
  deferred purchase consideration, net of current portion            9,586,000 9,519,000 19,419,000 19,319,000      
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 50,014 and 42,286 shares issued and outstanding, respectively          50,000           
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 100,307 and 106,807 shares issued and outstanding, respectively          100,000           
  investment securities available-for-sale, current           6,127,000          
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 48,673 and 42,286 shares issued and outstanding, respectively           49,000          
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 101,307 and 106,807 shares issued and outstanding, respectively           101,000 101,000         
  investment securities available for sale, current            6,943,000         
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 48,316 and 42,286 shares issued and outstanding, respectively            48,000         
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 42,561 and 42,286 shares issued and outstanding, respectively             42,000        
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 106,807 shares issued and outstanding             107,000        
  deferred revenue              237,344,000 211,036,000 210,587,000 204,971,000 207,560,000 185,445,000 187,041,000 
  current portion of capital lease obligations                     
  deferred rent and other                  939,000 908,000 917,000 
  capital lease obligations, net of current portion                     
  class a voting common stock, 0.001 par value, 300,000 shares authorized; 42,286 and 26,327 shares issued and outstanding, respectively              42,000       
  class b voting common stock, 0.001 par value, 150,000 shares authorized; 106,807 and 120,117 shares issued and outstanding, respectively              107,000       
  distributions payable                 2,700,000 2,700,000   
  accrued and deferred compensation, current               23,101,000 15,648,000     
  class a common stock               41,000 40,000 27,000    
  class b common stock               108,000 108,000 120,000    
  liabilities and equity                     
  total liabilities and equity                 558,337,000 554,928,000 514,934,000 258,490,000 
  purchase commitment liability, current                  845,000   
  long-term debt, net of current portion                  225,000 329,000 173,361,000 
  purchase commitment liability, net of current portion                  8,905,000   
  options for redeemable shares                    47,223,000 
  stockholders' equity                     
  preferred shares, 0.001 par value, 30,000 and 0 shares authorized; 0 and 0 shares issued and outstanding                     
  class a voting common stock, 0.001 par value, 0 and 600 shares authorized; 0 and 300 shares issued; 0 and 147 shares outstanding                     
  class b non-voting common stock, 0.001 par value, 0 and 299,400 shares authorized; 0 and 162,297 shares issued; 0 and 120,270 shares outstanding                     
  class a voting common stock, 0.001 par value, 300,000 and 0 shares authorized; 26,327 and 0 shares issued and outstanding                  26,000   
  class b voting common stock, 0.001 par value, 150,000 and 0 shares authorized; 120,117 and 0 shares issued and outstanding                  120,000   
  treasury stock                    -38,638,000 
  advances to stockholders                   2,000 230,000 
  goodwill                   18,667,000 19,355,000 
  deposits and other assets                   3,093,000 4,956,000 
  future acquisition commitment, current                   780,000 808,000 
  future acquisition commitment, net of current portion                   9,485,000 9,831,000 
  preferred shares, 0.001 par value, 30,000 and 0 shares authorized, respectively; 0 and 0 shares issued and outstanding, respectively                     
  class a voting common stock, 0.001 par value, 0 and 600 shares authorized, respectively; 0 and 300 shares issued, respectively; 0 and 147 shares outstanding, respectively                     
  class b non-voting common stock, 0.001 par value, 0 and 299,400 shares authorized, respectively; 0 and 162,297 shares issued, respectively; 0 and 120,270 shares outstanding, respectively                     
  class a voting common stock, 0.001 par value, 300,000 and 0 shares authorized, respectively; 25,688 and 0 shares issued and outstanding, respectively                   26,000  
  class b voting common stock, 0.001 par value, 150,000 and 0 shares authorized, respectively; 120,417 and 0 shares issued and outstanding, respectively                   120,000  
  stockholders’ deficit                     
  class a voting common stock, 0.001 par value, 600 shares authorized, 300 shares issued, 147 shares outstanding                     
  class b non-voting common stock, 0.001 par value, 299,400 shares authorized, 162,470 (unaudited), and 162,297 shares issued, respectively, 120,443 (unaudited) and 120,270 shares outstanding, respectively                    54,000 
  total stockholders’ deficit                    -348,210,000 

We provide you with 20 years of balance sheets for Vertex Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Vertex Pharmaceuticals. Explore the full financial landscape of Vertex Pharmaceuticals stock with our expertly curated balance sheets.

The information provided in this report about Vertex Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.